CRESCENT BIOPHARMA, INC. Shares Outstanding
CRESCENT BIOPHARMA, INC. (CBIO) had Shares Outstanding of 27.76 million shares as of 2026-06-30, per its 10-Q filed 2026-07-30.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-07-30
- 2026-06-30: Shares outstanding (split-adjusted) 27.76M shares; Shares authorized (split-adjusted) 175.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 27.57M shares; Shares authorized (split-adjusted) 175.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 27.56M shares; Shares authorized (split-adjusted) 175.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 13.89M shares; Shares authorized (split-adjusted) 175.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 27.76M shares 10-Q · filed 2026-07-30 | 175.00M shares 10-Q · filed 2026-07-30 |
| 2026-03-31 | 27.57M shares 10-Q · filed 2026-04-29 | 175.00M shares 10-Q · filed 2026-04-29 |
| 2025-12-31 | 27.56M shares 10-Q · filed 2026-07-30 | 175.00M shares 10-Q · filed 2026-07-30 |
| 2025-09-30 | 13.89M shares 10-Q · filed 2025-11-06 | 175.00M shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 13.89M shares 10-Q · filed 2025-07-31 | 175.00M shares 10-Q · filed 2025-07-31 |
| 2025-03-31 | 64.53M shares 10-Q · filed 2025-05-14 | 150.00M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 1.02M shares 10-K · filed 2026-02-26 | 40.00M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 64.48M shares 10-Q · filed 2024-11-13 | 150.00M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 64.48M shares 10-Q · filed 2024-08-08 | 150.00M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 64.45M shares 10-Q · filed 2024-05-09 | 100.00M shares 10-Q · filed 2024-11-13 |
| 2023-12-31 | 64.39M shares 10-K · filed 2025-02-13 | 100.00M shares 10-Q · filed 2025-05-14 |
| 2023-09-30 | 64.37M shares 10-Q · filed 2023-11-03 | 100.00M shares 10-Q · filed 2023-11-03 |
| 2023-06-30 | 64.31M shares 10-Q · filed 2023-08-02 | 100.00M shares 10-Q · filed 2023-08-02 |
| 2023-03-31 | 64.25M shares 10-Q · filed 2023-05-03 | 100.00M shares 10-Q · filed 2023-05-03 |
| 2022-12-31 | 54.38M shares 10-K · filed 2024-03-27 | 100.00M shares 10-K · filed 2024-03-27 |
| 2022-09-30 | 52.42M shares 10-Q · filed 2022-11-09 | 100.00M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 52.42M shares 10-Q · filed 2022-08-03 | 100.00M shares 10-Q · filed 2022-08-03 |
| 2022-03-31 | 51.74M shares 10-Q · filed 2022-04-28 | 100.00M shares 10-Q · filed 2022-04-28 |
| 2021-12-31 | 52.31M shares 10-K · filed 2023-03-29 | 100.00M shares 10-K · filed 2023-03-29 |
| 2021-09-30 | 51.74M shares 10-Q · filed 2021-11-02 | 100.00M shares 10-Q · filed 2021-11-02 |
| 2021-06-30 | 51.54M shares 10-Q · filed 2021-08-05 | 100.00M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 51.54M shares 10-Q · filed 2021-05-03 | 100.00M shares 10-Q · filed 2021-05-03 |
| 2020-12-31 | 49.02M shares 10-K · filed 2022-03-03 | 100.00M shares 10-K · filed 2022-03-03 |
| 2020-09-30 | 47.83M shares 10-Q · filed 2020-11-06 | 100.00M shares 10-Q · filed 2020-11-06 |
| 2020-06-30 | 46.71M shares 10-Q · filed 2020-07-31 | 100.00M shares 10-Q · filed 2020-07-31 |
| 2020-03-31 | 43.58M shares 10-Q · filed 2020-05-01 | 100.00M shares 10-Q · filed 2020-05-01 |
| 2019-12-31 | 43.47M shares 10-K · filed 2021-03-02 | 100.00M shares 10-K · filed 2021-03-02 |
| 2019-09-30 | 43.36M shares 10-Q · filed 2019-11-07 | 100.00M shares 10-Q · filed 2019-11-07 |
| 2019-06-30 | 43.19M shares 10-Q · filed 2019-08-01 | 100.00M shares 10-Q · filed 2019-08-01 |
| 2019-03-31 | 43.18M shares 10-Q · filed 2019-05-02 | 100.00M shares 10-Q · filed 2019-05-02 |
| 2018-12-31 | 43.16M shares 10-K · filed 2020-02-28 | 100.00M shares 10-K · filed 2020-02-28 |
| 2018-09-30 | 43.14M shares 10-Q · filed 2018-11-02 | 100.00M shares 10-Q · filed 2018-11-02 |
| 2018-06-30 | 43.06M shares 10-Q · filed 2018-08-09 | 100.00M shares 10-Q · filed 2018-08-09 |
| 2018-03-31 | 42.49M shares 10-Q · filed 2018-05-03 | 100.00M shares 10-Q · filed 2018-05-03 |
| 2017-12-31 | 34.36M shares 10-K · filed 2019-03-06 | 100.00M shares 10-K · filed 2019-03-06 |
| 2017-09-30 | 32.74M shares 10-Q · filed 2017-11-08 | 100.00M shares 10-Q · filed 2017-11-08 |
| 2017-06-30 | 32.72M shares 10-Q · filed 2017-08-03 | 100.00M shares 10-Q · filed 2017-08-03 |
| 2017-03-31 | 23.86M shares 10-Q · filed 2017-05-08 | 100.00M shares 10-Q · filed 2017-05-08 |
| 2016-12-31 | 23.25M shares 10-K · filed 2018-03-06 | 100.00M shares 10-K · filed 2018-03-06 |
| 2016-09-30 | 23.06M shares 10-Q · filed 2016-11-04 | 100.00M shares 10-Q · filed 2016-11-04 |
| 2016-06-30 | 23.03M shares 10-Q · filed 2016-08-04 | 100.00M shares 10-Q · filed 2016-08-04 |
| 2016-03-31 | 19.28M shares 10-Q · filed 2016-05-04 | 100.00M shares 10-Q · filed 2016-05-04 |
| 2015-12-31 | 19.05M shares 10-K · filed 2017-03-01 | 100.00M shares 10-K · filed 2017-03-01 |
| 2015-09-30 | 19.04M shares 10-Q · filed 2015-11-12 | 100.00M shares 10-Q · filed 2015-11-12 |
| 2015-06-30 | 19.02M shares 10-Q · filed 2015-08-06 | 100.00M shares 10-Q · filed 2015-08-06 |
| 2015-03-31 | 19.01M shares 10-Q · filed 2015-05-05 | 100.00M shares 10-Q · filed 2015-05-05 |
| 2014-12-31 | 18.94M shares 10-K · filed 2016-02-29 | 100.00M shares 10-K · filed 2016-02-29 |
| 2014-09-30 | 18.89M shares 10-Q · filed 2014-10-31 | 100.00M shares 10-Q · filed 2014-10-31 |
| 2014-06-30 | 18.89M shares 10-Q · filed 2014-07-31 | 100.00M shares 10-Q · filed 2014-07-31 |
| 2014-03-31 | 18.78M shares 10-Q · filed 2014-05-09 | 100.00M shares 10-Q · filed 2014-05-09 |
| 2013-12-31 | 1.43M shares 10-K · filed 2015-03-16 | 70.26M shares 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |